{"id":1076,"date":"2017-08-01T06:35:43","date_gmt":"2017-08-01T06:35:43","guid":{"rendered":"https:\/\/xavant.com\/?p=1076"},"modified":"2018-10-15T16:38:32","modified_gmt":"2018-10-15T14:38:32","slug":"stimpod-nms460-receives-fda-clearance-usa","status":"publish","type":"post","link":"https:\/\/xavant.com\/es\/stimpod-nms460-receives-fda-clearance-usa\/","title":{"rendered":"Stimpod NMS460 recibe la autorizaci\u00f3n de la FDA (EE.UU.)"},"content":{"rendered":"<div class=\"wpb-content-wrapper\"><div class=\"vc_row wpb_row vc_row-fluid\"><div class=\"wpb_column vc_column_container vc_col-sm-12\"><div class=\"vc_column-inner\"><div class=\"wpb_wrapper\">\n\t<div class=\"wpb_text_column wpb_content_element\" >\n\t\t<div class=\"wpb_wrapper\">\n\t\t\t<p><strong>Pretoria, Sud\u00e1frica<\/strong>\u00a0- Xavant Technology (Pty) Ltd ha anunciado hoy que la Administraci\u00f3n de Alimentos y Medicamentos de EE.UU. (FDA) ha autorizado su Stimpod NMS460. Este dispositivo de neuromodulaci\u00f3n no invasiva, cuya forma de onda patentada de radiofrecuencia pulsada (PRF) h\u00edbrida ha sido patentada en EE.UU., se centra en el alivio sintom\u00e1tico y el tratamiento del dolor cr\u00f3nico intratable, as\u00ed como en el tratamiento complementario del dolor posquir\u00fargico, los problemas de dolor agudo postraum\u00e1tico y el control del dolor durante la rehabilitaci\u00f3n.<\/p>\n<p>La necesidad de este dispositivo es profunda. M\u00e1s de 100 millones de estadounidenses afirman tener problemas de dolor.<a href=\"https:\/\/www.stimpodnms460.com\/news\/#_ftn1\" name=\"_ftnref1\">[1]<\/a>\u00a0\u00a0El dolor cr\u00f3nico se caracteriza por cambios neuropl\u00e1sticos que provocan la sensibilizaci\u00f3n del sistema nervioso. Estos cambios dan lugar a alteraciones anat\u00f3micas y fisiol\u00f3gicas que afectan a la funci\u00f3n neurol\u00f3gica, lo que provoca una potenciaci\u00f3n a largo plazo y cambios en la expresi\u00f3n g\u00e9nica que permiten que el dolor contin\u00fae con o sin otra entrada perif\u00e9rica, y un umbral del dolor m\u00e1s bajo; esta disfunci\u00f3n tambi\u00e9n explica los epifen\u00f3menos asociados a la enfermedad, como los cambios emocionales, de memoria y motores, que se convierten en la enfermedad del dolor cr\u00f3nico.<a href=\"https:\/\/www.stimpodnms460.com\/news\/#_ftn2\" name=\"_ftnref2\">[2]<\/a><\/p>\n<p>Se calcula que el tratamiento del dolor cr\u00f3nico en Estados Unidos cuesta $600.000 millones al a\u00f1o.<a href=\"https:\/\/www.stimpodnms460.com\/news\/#_ftn3\" name=\"_ftnref3\">[3]<\/a>\u00a0El tratamiento est\u00e1ndar actual del dolor cr\u00f3nico incluye c\u00f3cteles de f\u00e1rmacos como corticosteroides, analg\u00e9sicos opi\u00e1ceos, inyecciones, etc., combinados con tratamientos como fisioterapia y asesoramiento. Los tratamientos pueden tener efectos secundarios a corto y largo plazo.<\/p>\n<p>El Stimpod NMS460, sin embargo, tendr\u00e1 un gran impacto en la industria como una soluci\u00f3n no invasiva, sin f\u00e1rmacos, con cero efectos secundarios y un r\u00e1pido inicio del efecto a una fracci\u00f3n del coste de los tratamientos comparables. El dispositivo aplica su forma de onda PRF patentada a la zona afectada de forma transcut\u00e1nea. Esta forma de onda crea efectos electromagn\u00e9ticos similares a los tratamientos invasivos de radiofrecuencia pulsada, y varios estudios de casos han demostrado un alivio instant\u00e1neo y espectacular del dolor cr\u00f3nico intratable. El Stimpod NMS460 tambi\u00e9n incorpora la tecnolog\u00eda de localizaci\u00f3n de nervios que cuenta con una sonda de mapeo de nervios que permite a los profesionales localizar los nervios y evaluar el progreso del tratamiento de los nervios da\u00f1ados. Bell Medical ha sido seleccionado como distribuidor principal tanto para EE.UU. como para Canad\u00e1.<\/p>\n<p>\"Estamos encantados con la noticia de que nuestro revolucionario dispositivo pueda utilizarse ahora en Estados Unidos\", ha declarado Corlius Birkill, Director General de Xavant Technology (Pty) Ltd. \"Esta tecnolog\u00eda innovadora tiene la capacidad de ayudar a decenas, si no cientos, de millones de personas s\u00f3lo en los EE.UU. como un valioso recurso de tratamiento para neur\u00f3logos, quiropr\u00e1cticos, acupuntores, fisioterapeutas, fisiatras y m\u00e9dicos del dolor.\"<\/p>\n<p><a href=\"https:\/\/www.stimpodnms460.com\/news\/#_ftnref1\" name=\"_ftn1\">[1]<\/a>\u00a0Gaskin, Darrell J., y Patrick Richard. \"Los costes econ\u00f3micos del dolor en Estados Unidos\".\u00a0<em>The Journal of Pain: Revista oficial de la Sociedad Americana del Dolor<\/em>\u00a0(2012): 715-24. Web. 21 de junio de 2017.<\/p>\n<p><a href=\"https:\/\/www.stimpodnms460.com\/news\/#_ftnref2\" name=\"_ftn2\">[2]<\/a>\u00a0Academia Americana de Medicina del Dolor.\u00a0<em>El dolor neurop\u00e1tico se reconoce como enfermedad<\/em>. N.p.: Asociaci\u00f3n M\u00e9dica Americana, 27 de septiembre de 2016. PDF.\u00a0<a href=\"https:\/\/assets.ama-assn.org\/sub\/meeting\/documents\/i16-resolution-912.pdf\" target=\"_blank\" rel=\"noopener\">https:\/\/assets.ama-assn.org\/sub\/meeting\/documents\/i16-resolution-912.pdf<\/a><\/p>\n<p><a href=\"https:\/\/www.stimpodnms460.com\/news\/#_ftnref3\" name=\"_ftn3\">[3]<\/a>\u00a0Gaskin, Darrell J., y Patrick Richard. \"Los costes econ\u00f3micos del dolor en Estados Unidos\".\u00a0<em>The Journal of Pain: Revista oficial de la Sociedad Americana del Dolor<\/em>\u00a0(2012): 715-24. Web. 21 de junio de 2017.<\/p>\n\n\t\t<\/div>\n\t<\/div>\n<\/div><\/div><\/div><\/div>\n<\/div>","protected":false},"excerpt":{"rendered":"<p>Pretoria, Sud\u00e1frica - Xavant Technology (Pty) Ltd ha anunciado hoy que la Food and Drug Administration (FDA) de EE.UU. ha autorizado su Stimpod NMS460. Este dispositivo de neuromodulaci\u00f3n no invasiva, cuya forma de onda patentada de radiofrecuencia pulsada (PRF) h\u00edbrida ha sido patentada en EE.UU., se centra en el alivio sintom\u00e1tico y el tratamiento del dolor cr\u00f3nico intratable, as\u00ed como...<\/p>","protected":false},"author":2,"featured_media":1077,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[7],"tags":[],"class_list":["post-1076","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-news","category-7","description-off"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.4 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Stimpod NMS460 Receives FDA Clearance (USA) | Xavant Technology | TOF Monitors, NMT Monitoring, Nerve Mapping<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/xavant.com\/es\/stimpod-nms460-receives-fda-clearance-usa\/\" \/>\n<meta property=\"og:locale\" content=\"es_ES\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Stimpod NMS460 Receives FDA Clearance (USA) | Xavant Technology | TOF Monitors, NMT Monitoring, Nerve Mapping\" \/>\n<meta property=\"og:url\" content=\"https:\/\/xavant.com\/es\/stimpod-nms460-receives-fda-clearance-usa\/\" \/>\n<meta property=\"og:site_name\" content=\"Xavant Technology | TOF Monitors, NMT Monitoring, Nerve Mapping\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/XavantTechnology\/\" \/>\n<meta property=\"article:published_time\" content=\"2017-08-01T06:35:43+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2018-10-15T14:38:32+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/xavant.com\/wp-content\/uploads\/2018\/08\/fda-cleared_news.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"400\" \/>\n\t<meta property=\"og:image:height\" content=\"314\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Xavant Technology\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@XavantTech\" \/>\n<meta name=\"twitter:site\" content=\"@XavantTech\" \/>\n<meta name=\"twitter:label1\" content=\"Escrito por\" \/>\n\t<meta name=\"twitter:data1\" content=\"Xavant Technology\" \/>\n\t<meta name=\"twitter:label2\" content=\"Tiempo de lectura\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutos\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/xavant.com\\\/stimpod-nms460-receives-fda-clearance-usa\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/xavant.com\\\/stimpod-nms460-receives-fda-clearance-usa\\\/\"},\"author\":{\"name\":\"Xavant Technology\",\"@id\":\"https:\\\/\\\/xavant.com\\\/#\\\/schema\\\/person\\\/c8384e46abaf5f32420beb9c3d237ac9\"},\"headline\":\"Stimpod NMS460 Receives FDA Clearance (USA)\",\"datePublished\":\"2017-08-01T06:35:43+00:00\",\"dateModified\":\"2018-10-15T14:38:32+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/xavant.com\\\/stimpod-nms460-receives-fda-clearance-usa\\\/\"},\"wordCount\":512,\"publisher\":{\"@id\":\"https:\\\/\\\/xavant.com\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/xavant.com\\\/stimpod-nms460-receives-fda-clearance-usa\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/xavant.com\\\/wp-content\\\/uploads\\\/2018\\\/08\\\/fda-cleared_news.jpg\",\"articleSection\":[\"News\"],\"inLanguage\":\"es\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/xavant.com\\\/stimpod-nms460-receives-fda-clearance-usa\\\/\",\"url\":\"https:\\\/\\\/xavant.com\\\/stimpod-nms460-receives-fda-clearance-usa\\\/\",\"name\":\"Stimpod NMS460 Receives FDA Clearance (USA) | Xavant Technology | TOF Monitors, NMT Monitoring, Nerve Mapping\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/xavant.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/xavant.com\\\/stimpod-nms460-receives-fda-clearance-usa\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/xavant.com\\\/stimpod-nms460-receives-fda-clearance-usa\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/xavant.com\\\/wp-content\\\/uploads\\\/2018\\\/08\\\/fda-cleared_news.jpg\",\"datePublished\":\"2017-08-01T06:35:43+00:00\",\"dateModified\":\"2018-10-15T14:38:32+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/xavant.com\\\/stimpod-nms460-receives-fda-clearance-usa\\\/#breadcrumb\"},\"inLanguage\":\"es\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/xavant.com\\\/stimpod-nms460-receives-fda-clearance-usa\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\\\/\\\/xavant.com\\\/stimpod-nms460-receives-fda-clearance-usa\\\/#primaryimage\",\"url\":\"https:\\\/\\\/xavant.com\\\/wp-content\\\/uploads\\\/2018\\\/08\\\/fda-cleared_news.jpg\",\"contentUrl\":\"https:\\\/\\\/xavant.com\\\/wp-content\\\/uploads\\\/2018\\\/08\\\/fda-cleared_news.jpg\",\"width\":400,\"height\":314},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/xavant.com\\\/stimpod-nms460-receives-fda-clearance-usa\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/xavant.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Stimpod NMS460 Receives FDA Clearance (USA)\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/xavant.com\\\/#website\",\"url\":\"https:\\\/\\\/xavant.com\\\/\",\"name\":\"Xavant Technology | TOF Monitors, NMT Monitoring, Nerve Mapping\",\"description\":\"Developers of Quantitative TOF Monitors (NMT Monitors), Nerve Mapping and Locating devices.\",\"publisher\":{\"@id\":\"https:\\\/\\\/xavant.com\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/xavant.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"es\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/xavant.com\\\/#organization\",\"name\":\"Xavant Technology\",\"url\":\"https:\\\/\\\/xavant.com\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\\\/\\\/xavant.com\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/xavant.com\\\/wp-content\\\/uploads\\\/2018\\\/10\\\/Xavant-Logo-Original-Colours.png\",\"contentUrl\":\"https:\\\/\\\/xavant.com\\\/wp-content\\\/uploads\\\/2018\\\/10\\\/Xavant-Logo-Original-Colours.png\",\"width\":1636,\"height\":306,\"caption\":\"Xavant Technology\"},\"image\":{\"@id\":\"https:\\\/\\\/xavant.com\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.facebook.com\\\/XavantTechnology\\\/\",\"https:\\\/\\\/x.com\\\/XavantTech\",\"https:\\\/\\\/www.linkedin.com\\\/company\\\/xavant-technology\\\/\"]},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/xavant.com\\\/#\\\/schema\\\/person\\\/c8384e46abaf5f32420beb9c3d237ac9\",\"name\":\"Xavant Technology\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/cc3d4616cfe17ac20387a5ebea88c52e96b171c5c1871830086f4e836a604974?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/cc3d4616cfe17ac20387a5ebea88c52e96b171c5c1871830086f4e836a604974?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/cc3d4616cfe17ac20387a5ebea88c52e96b171c5c1871830086f4e836a604974?s=96&d=mm&r=g\",\"caption\":\"Xavant Technology\"}}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Stimpod NMS460 Recibe la Autorizaci\u00f3n de la FDA (EE.UU.) | Xavant Technology | Monitores TOF, Monitorizaci\u00f3n NMT, Mapeo Nervioso","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/xavant.com\/es\/stimpod-nms460-receives-fda-clearance-usa\/","og_locale":"es_ES","og_type":"article","og_title":"Stimpod NMS460 Receives FDA Clearance (USA) | Xavant Technology | TOF Monitors, NMT Monitoring, Nerve Mapping","og_url":"https:\/\/xavant.com\/es\/stimpod-nms460-receives-fda-clearance-usa\/","og_site_name":"Xavant Technology | TOF Monitors, NMT Monitoring, Nerve Mapping","article_publisher":"https:\/\/www.facebook.com\/XavantTechnology\/","article_published_time":"2017-08-01T06:35:43+00:00","article_modified_time":"2018-10-15T14:38:32+00:00","og_image":[{"width":400,"height":314,"url":"https:\/\/xavant.com\/wp-content\/uploads\/2018\/08\/fda-cleared_news.jpg","type":"image\/jpeg"}],"author":"Xavant Technology","twitter_card":"summary_large_image","twitter_creator":"@XavantTech","twitter_site":"@XavantTech","twitter_misc":{"Escrito por":"Xavant Technology","Tiempo de lectura":"3 minutos"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/xavant.com\/stimpod-nms460-receives-fda-clearance-usa\/#article","isPartOf":{"@id":"https:\/\/xavant.com\/stimpod-nms460-receives-fda-clearance-usa\/"},"author":{"name":"Xavant Technology","@id":"https:\/\/xavant.com\/#\/schema\/person\/c8384e46abaf5f32420beb9c3d237ac9"},"headline":"Stimpod NMS460 Receives FDA Clearance (USA)","datePublished":"2017-08-01T06:35:43+00:00","dateModified":"2018-10-15T14:38:32+00:00","mainEntityOfPage":{"@id":"https:\/\/xavant.com\/stimpod-nms460-receives-fda-clearance-usa\/"},"wordCount":512,"publisher":{"@id":"https:\/\/xavant.com\/#organization"},"image":{"@id":"https:\/\/xavant.com\/stimpod-nms460-receives-fda-clearance-usa\/#primaryimage"},"thumbnailUrl":"https:\/\/xavant.com\/wp-content\/uploads\/2018\/08\/fda-cleared_news.jpg","articleSection":["News"],"inLanguage":"es"},{"@type":"WebPage","@id":"https:\/\/xavant.com\/stimpod-nms460-receives-fda-clearance-usa\/","url":"https:\/\/xavant.com\/stimpod-nms460-receives-fda-clearance-usa\/","name":"Stimpod NMS460 Recibe la Autorizaci\u00f3n de la FDA (EE.UU.) | Xavant Technology | Monitores TOF, Monitorizaci\u00f3n NMT, Mapeo Nervioso","isPartOf":{"@id":"https:\/\/xavant.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/xavant.com\/stimpod-nms460-receives-fda-clearance-usa\/#primaryimage"},"image":{"@id":"https:\/\/xavant.com\/stimpod-nms460-receives-fda-clearance-usa\/#primaryimage"},"thumbnailUrl":"https:\/\/xavant.com\/wp-content\/uploads\/2018\/08\/fda-cleared_news.jpg","datePublished":"2017-08-01T06:35:43+00:00","dateModified":"2018-10-15T14:38:32+00:00","breadcrumb":{"@id":"https:\/\/xavant.com\/stimpod-nms460-receives-fda-clearance-usa\/#breadcrumb"},"inLanguage":"es","potentialAction":[{"@type":"ReadAction","target":["https:\/\/xavant.com\/stimpod-nms460-receives-fda-clearance-usa\/"]}]},{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/xavant.com\/stimpod-nms460-receives-fda-clearance-usa\/#primaryimage","url":"https:\/\/xavant.com\/wp-content\/uploads\/2018\/08\/fda-cleared_news.jpg","contentUrl":"https:\/\/xavant.com\/wp-content\/uploads\/2018\/08\/fda-cleared_news.jpg","width":400,"height":314},{"@type":"BreadcrumbList","@id":"https:\/\/xavant.com\/stimpod-nms460-receives-fda-clearance-usa\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/xavant.com\/"},{"@type":"ListItem","position":2,"name":"Stimpod NMS460 Receives FDA Clearance (USA)"}]},{"@type":"WebSite","@id":"https:\/\/xavant.com\/#website","url":"https:\/\/xavant.com\/","name":"Xavant Technology | Monitores TOF, monitorizaci\u00f3n NMT, cartograf\u00eda nerviosa","description":"Desarrolladores de monitores TOF cuantitativos (monitores NMT) y dispositivos de cartograf\u00eda y localizaci\u00f3n nerviosa.","publisher":{"@id":"https:\/\/xavant.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/xavant.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"es"},{"@type":"Organization","@id":"https:\/\/xavant.com\/#organization","name":"Tecnolog\u00eda Xavant","url":"https:\/\/xavant.com\/","logo":{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/xavant.com\/#\/schema\/logo\/image\/","url":"https:\/\/xavant.com\/wp-content\/uploads\/2018\/10\/Xavant-Logo-Original-Colours.png","contentUrl":"https:\/\/xavant.com\/wp-content\/uploads\/2018\/10\/Xavant-Logo-Original-Colours.png","width":1636,"height":306,"caption":"Xavant Technology"},"image":{"@id":"https:\/\/xavant.com\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/XavantTechnology\/","https:\/\/x.com\/XavantTech","https:\/\/www.linkedin.com\/company\/xavant-technology\/"]},{"@type":"Person","@id":"https:\/\/xavant.com\/#\/schema\/person\/c8384e46abaf5f32420beb9c3d237ac9","name":"Tecnolog\u00eda Xavant","image":{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/secure.gravatar.com\/avatar\/cc3d4616cfe17ac20387a5ebea88c52e96b171c5c1871830086f4e836a604974?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/cc3d4616cfe17ac20387a5ebea88c52e96b171c5c1871830086f4e836a604974?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/cc3d4616cfe17ac20387a5ebea88c52e96b171c5c1871830086f4e836a604974?s=96&d=mm&r=g","caption":"Xavant Technology"}}]}},"_links":{"self":[{"href":"https:\/\/xavant.com\/es\/wp-json\/wp\/v2\/posts\/1076","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/xavant.com\/es\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/xavant.com\/es\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/xavant.com\/es\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/xavant.com\/es\/wp-json\/wp\/v2\/comments?post=1076"}],"version-history":[{"count":0,"href":"https:\/\/xavant.com\/es\/wp-json\/wp\/v2\/posts\/1076\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/xavant.com\/es\/wp-json\/wp\/v2\/media\/1077"}],"wp:attachment":[{"href":"https:\/\/xavant.com\/es\/wp-json\/wp\/v2\/media?parent=1076"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/xavant.com\/es\/wp-json\/wp\/v2\/categories?post=1076"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/xavant.com\/es\/wp-json\/wp\/v2\/tags?post=1076"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}